FMR1 Testing – Current Technologies and New Advances in CGG Repeat Quantification and Categorization

An educational webinar sponsored by Asuragen, Inc. and the Association for Molecular Pathology (AMP)

Date:
Tuesday, April 10, 2012
Time:
12:00 – 1:00 PM PDT
3:00 – 4:00 PM EDT
Registration:

Featuring:

Sue Richards, PhD, FACMG
Professor, Molecular & Medical Genetics
Director, Clinical Molecular Genetics
Oregon Health Science University

Objectives of this webinar:

  • To gain a comprehensive understanding of the existing approaches for FMR1 testing, including both lab developed tests (LDT’s) and commercial options
  • To review challenges and advantages that these offer to a clinical molecular diagnostic lab

For more information, contact Jane Papadaki Markley at jmarkley@asuragen.com


This is part 1 of a 4 part FMR1 educational webinar series sponsored by Asuragen, Inc. & the Association for Molecular Pathology (AMP)

  • Webinar #1 – 4.10.2012
    FMR1 testing – current technologies and new advances in CGG repeat quantification and categorization
    Speaker: Sue Richards, PhD, FACMG / Oregon Health Science University
  • Webinar #2 – 6.20.2012
    Reclassification of FMR1 expansion risk: The role of AGG Interruptions
    Speaker: Liz Berry-Kravis, MD, PhD / Rush
    Brad Coffee, PhD / Emory University School of Medicine
  • Webinar #3 – July 25, 2012
    FMR1 Methylation PCR – eliminating the need for Southern Blot testing
    Speaker: Elaine Lyon, PhD / ARUP Laboratories
  • Webinar #4 – September 18, 2012
    FMR1 Carrier Screening – the how, the why, and the when
    Speaker: Brad Coffee, PhD / Emory University School of Medicine